Ann: Race Strategic Update August 2023, page-549

First 549 Last

Share
Profile

Follow
johndprent

2,982 Posts.

3623

16/11/23

06:37

Post #: 70927938
Share

Originally posted by LongTony: ↑

Hi Titans (and Hunterr just above this post), the strategy last time was the John Cullity 2025 $10 per share best case buyout, dilution, value destruction sh!t show. After picking it apart while I was in Edinburgh* where I separately briefly met with a renowned HC poster, it occurred to me that the reason it felt "off" was that it was created under a walking cadaver whose Ape Brain can't let him believe that it could ever be worth over $10/share so he did everything in his power to keep its maximum upside below there.

In discussions, JC acknowledged that the Triangle report was not going to confound my 'back of the envelope' minimum $5Bn USD per annum revenue for COACS calculation, yet hIs eyes flashed with anger when I asked him why he couldn't believe a share price value above $10.

RAC then developed a strategy that made $10 look like a good outcome: expensive, slow and with heaps of dilution. It suited Australian Biotech's own Count Dracula, down to a T.

Alignment to Big Pharma was a plus, but it came with the clear dilution and slow progress; meaning big Pharma could pick it up cheap.

Our old chairman's day job was serving big Pharma, and that conflict of interest had a pretty big hand in him putting fwd a strategy that served big Pharma IMhO, rather than appealing to their interests and serving shareholders and patients of bisantrene.

*I messaged Le Raz on our top secret, encrypted App when I realised the above whilst walking through Edinburgh back in August, and if they weren't a band of anonymous super heroes, they could attest to the veracity of this story.

Expand

Right outcome, wrong approach.

RAC Price at posting: 97.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint